Theravance Biopharma To Sell Remaining Interest In Trelegy Ellipta To GSK For $225 Mln, Stock Up
https://www.rttnews.com/story.aspx?Id=3543458
Jun 02, 2025 - Theravance Biopharma, Inc. (TBPH), Monday announced an agreement to sell remaining interest in net sales of Trelegy Ellipta, a chronic obstructive pulmonary disease or asthma treatment, to GSK (GSK) for $225 million in cash.
0
UP Fintech Holding Limited (TIGR) Q1 2025 Earnings Call Transcript
https://seekingalpha.com/article/4791224-up-fintech-holding-limited-tigr-q1-2025-earnings-call-transcript?source=feed_sector_transcripts
May 30, 2025 -
0
2 Preferreds For A Stress-Free Retirement; Up To 8.7% Yield
https://seekingalpha.com/article/4790742-2-preferreds-for-stress-free-retirement-up-to-8-7-percent-yield?source=feed
May 30, 2025 -
0
Should San Diego move up the start date for paid parking at Balboa Park?
https://www.sandiegouniontribune.com/2025/05/30/should-san-diego-move-up-the-start-date-for-paid-parking-at-balboa-park/
May 30, 2025 - Moving up the date for paid Balboa Park parking could generate $11 million, projection says.
0
When $7 Trillion Wakes Up: Buy These 3 Dividend Stocks Before Everyone Else Does
https://seekingalpha.com/article/4790452-when-7-trillion-wakes-up-buy-3-dividend-stocks-before-everyone-else?source=feed
May 29, 2025 -
0
Alcon up 4% as FDA approves Tryptyr drops for dry eye
https://seekingalpha.com/news/4453225-alcon-up-4-percent-fda-approves-tryptyr-drops-dry-eye?source=feed_sector_healthcare
May 28, 2025 -
0
Malibu Barbie Cafe will pop up in San Diego in July
https://www.sandiegouniontribune.com/2025/05/28/malibu-barbie-cafe-will-pop-up-in-san-diego-in-july/
May 28, 2025 - The bubble-gum pink, '70s-themed restaurant and skating rink will serve up selfies and an all-day fast-casual menu
0
Monro Slips To Q4 Loss, Sales Beat Market, Comps Up In Q1-to-date; Stock Climbs
https://www.rttnews.com/story.aspx?Id=3542529
May 28, 2025 - Monro, Inc. (MNRO), a provider of automotive undercar repair and tire services, reported Wednesday a loss in its fourth quarter, compared to prior year's profit, amid weak sales. The topline, however, beat market estimates, with higher comparable store sales. The company further reported higher Comparable store sales in the first-quarter-to date, and announced dividend.
0
Spero Therapeutics, GSK Say Phase 3 PIVOT-PO Study Of Tebipenem HBr Met Primary Goal; Spero Stock Up
https://www.rttnews.com/story.aspx?Id=3542464
May 28, 2025 - Spero Therapeutics, Inc.(SPRO) and GSK plc (GSK) Wednesday reported that the pivotal Phase 3 PIVOT-PO study of tebipenem HBr in complicated urinary tract infections (cUTIs), including
pyelonephritis, met its primary goal and will stop early for efficacy. This news sent Spero stock up over 250% in pre-market activity.
0
Veru Announces Positive Safety Data Of Enobosarm+Semaglutide Therapy, Stock Up In Pre-Market
https://www.rttnews.com/story.aspx?Id=3542458
May 28, 2025 - Veru Inc. (VERU), Wednesday announced positive topline safety results from the Phase 2b QUALITY clinical trial, evaluating the safety and efficacy of enobosarm 3mg, enobosarm 6mg, or placebo as a treatment to enhance fat loss and to prevent muscle loss in older patients receiving semaglutide.
0